Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.02−0.02 (-0.98%)
Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –
Compugen operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was $31.63M, down 36.2% from the year before. The highest annual figure on record is $49.60M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.63M | -36.2% |
| FY2024 | Dec 31, 2024 | $49.60M | – |
| FY2023 | Dec 31, 2023 | -$35.89M | – |
| FY2022 | Dec 31, 2022 | -$34.11M | – |
| FY2021 | Dec 31, 2021 | -$22.69M | – |
| FY2020 | Dec 31, 2020 | -$28.32M | – |
| FY2019 | Dec 31, 2019 | -$27.89M | – |
| FY2018 | Dec 31, 2018 | -$13.29M | – |
| FY2017 | Dec 31, 2017 | -$30.66M | – |
| FY2016 | Dec 31, 2016 | -$19.82M | – |
| FY2015 | Dec 31, 2015 | -$25.61M | – |
| FY2014 | Dec 31, 2014 | -$11.15M | – |
| FY2013 | Dec 31, 2013 | -$6.44M | – |
| FY2012 | Dec 31, 2012 | -$10.85M | – |
| FY2011 | Dec 31, 2011 | -$9.25M | – |
| FY2010 | Dec 31, 2010 | -$4.28M | – |
| FY2009 | Dec 31, 2009 | -$7.45M | – |
See a number that looks wrong?